ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Xueting Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.